insights_auto
Why is NVAX up 15.80%?
Dive Deeperchevron_right
NVAX:NASDAQ
Novavax Inc
$ 12.75
arrow_upward
+15.80%(+1.74) 1D
$ 12.69
arrow_downward
-0.49% (-0.063)bedtimeAfter hours
Closed: 10-р сарын 9, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVAX...
Open
$ 11.17
High
$ 13.04
Low
$ 11.03
Mkt. cap
2.10 тэрбум
Avg. vol.
6.76 сая
Volume
19.03 сая
52-wk high
$ 13.38
52-wk low
$ 6.20
EPS
-$ 1.52
Beta
2.44
Shares outstanding
164.95 сая
No. of employees
749
Open
$ 11.17
High
$ 13.04
Low
$ 11.03
Mkt. cap
2.10 тэрбум
Avg. vol.
6.76 сая
Volume
19.03 сая
52-wk high
$ 13.38
52-wk low
$ 6.20
EPS
-$ 1.52
Beta
2.44
Shares outstanding
164.95 сая
No. of employees
749
News stories
From web sources and news partners
Yahoo Finance
·
10 цагийн өмнө
BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push
Benzinga
·
15 цагийн өмнө
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
24/7 Wall St.
·
16 цагийн өмнө
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Timothy Sykes
·
17 цагийн өмнө
NVAX Stock Grinds Higher As Traders Watch Volatile Rebound
Profile
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria.
Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
About Novavax Inc
CEOJohn C. Jacobs
Employees749
Founded1987
HeadquartersGaithersburg, Мэрилэнд, Америкийн Нэгдсэн Улс
Sector-
Websitenovavax.com